Histological Aggressiveness of Fluorodeoxyglucose Positron-emission Tomogram (FDG-PET)-detected Incidental Thyroid Carcinomas
Overview
Affiliations
Background: We previously reported a high incidence of primary thyroid cancer in fluorodeoxyglucose positron-emission tomogram (FDG-PET)-detected incidental thyroid abnormalities. The aim of our study was to determine if these FDG-PET-detected thyroid malignancies represent a more-aggressive variant of primary thyroid carcinoma.
Materials And Methods: All patients that underwent operative intervention for FDG-PET-detected incidental thyroid abnormalities were identified (June 2003 to April 2006). Patients with a diagnosis of primary thyroid carcinoma on final histopathology were included in the study. The patient demographics and histopathological findings were analyzed to identify adverse prognostic features.
Results: In 11,500 patients, 17,250 FDG-PET scans were performed; 377 of these patients (3.2% of patients and 2.1% of FDG-PET scans) had findings positive for thyroid abnormality. Of the 32 patients that underwent operative intervention, 22 patients with a final diagnosis of primary thyroid malignancy were included in the study. A greater number of patients [12 patients, (54%)] were noted to harbor poor prognostic variants of primary thyroid carcinoma on final histopathology [tall-cell variant: 11 patients (50%) and poorly differentiated thyroid carcinoma: 1 patient (4%)]. Extra-thyroidal extension (ETE) was noted in the majority of patients [14 patients (63%)]. In patients with tall cell variant on final histopathology, the rate of ETE was even higher [10 patients (90%)].
Conclusion: Thyroid malignancies incidentally detected on FDG-PET scan harbor a high rate of unfavorable prognostic features and may represent a more-aggressive variant of primary thyroid carcinoma. These patients need to be subjected to further investigation with a view to possible operative intervention.
Piccardo A, Bottoni G, Treglia G, Foppiani L, Mariani F, Catrambone U Eur J Nucl Med Mol Imaging. 2025; .
PMID: 39998675 DOI: 10.1007/s00259-025-07169-3.
Soyluoglu S, Tastekin E, Andac B, Korkmaz U, Orun S, Durmus Altun G Cureus. 2023; 15(9):e44751.
PMID: 37809246 PMC: 10556374. DOI: 10.7759/cureus.44751.
MANAGEMENT PRINCIPLES OF INCIDENTAL THYROID 18F-FDG UPTAKE IDENTIFIED ON 18F-FDG PET/CT IMAGING.
Akbas A, Dagmura H, Gul S, Dasiran F, Daldal E, Okan I Acta Endocrinol (Buchar). 2022; 18(2):253-257.
PMID: 36212269 PMC: 9512372. DOI: 10.4183/aeb.2022.253.
Scappaticcio L, Piccardo A, Treglia G, Poller D, Trimboli P Endocrine. 2021; 73(3):540-549.
PMID: 33761104 PMC: 8325664. DOI: 10.1007/s12020-021-02683-4.
EANM practice guideline/SNMMI procedure standard for RAIU and thyroid scintigraphy.
Giovanella L, Avram A, Iakovou I, Kwak J, Lawson S, Lulaj E Eur J Nucl Med Mol Imaging. 2019; 46(12):2514-2525.
PMID: 31392371 DOI: 10.1007/s00259-019-04472-8.